Publications by authors named "Almas Nuchjumroon"
Article Synopsis
- * A study of 188 kidney transplant recipients assessed the impact of CYP3A5 genetic variations on tacrolimus IPV, revealing that 58.5% were expressers and 41.5% were nonexpressers of CYP3A5.
- * Results showed no significant differences in tacrolimus IPV between expressers and nonexpressers, although expressers had lower overall drug concentrations; IPV was unaffected by CYP3A5 variations over 6 to 12 months post-transplant.
